Speak to a Novartis representative
Ask Speakers
Medical Information Request
ADAKVEO® has a conditional marketing authorisation and further evidence is awaited.
For more information, refer to the ADAKVEO® ▼ (crizanlizumab) prescribing information available here: https://www.health.novartis.co.uk/sites/health.novartis.co.uk/files/adak...
Legal Category: POM.
Marketing Authorisation (MA) number, quantities and price: EU/1/20/1476/001 £1,038.00 per 10ml vial
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]